SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-066229
Filing Date
2018-11-06
Accepted
2018-11-06 10:58:31
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19062_110q.htm 10-Q 1411058
2 EX-31.1 a18-19062_1ex31d1.htm EX-31.1 10676
3 EX-31.2 a18-19062_1ex31d2.htm EX-31.2 10691
4 EX-32.1 a18-19062_1ex32d1.htm EX-32.1 5434
5 EX-32.2 a18-19062_1ex32d2.htm EX-32.2 5449
  Complete submission text file 0001104659-18-066229.txt   5200491

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adap-20180930.xml EX-101.INS 1083187
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adap-20180930.xsd EX-101.SCH 38397
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adap-20180930_cal.xml EX-101.CAL 46904
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adap-20180930_def.xml EX-101.DEF 135432
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT adap-20180930_lab.xml EX-101.LAB 336147
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adap-20180930_pre.xml EX-101.PRE 259415
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37368 | Film No.: 181161974
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1